Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

SAVASAVA
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in FILANA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 668,792 shares of SAVA (FILANA THERAPEUTICS INC), worth $795,862 as of 2026-Q2. The position was increased (+1518.4% shares). SAVA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$795,862

Current Shares

668,792

Total Value Change

+$794,806

Total Shares Change

+631,235

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
668,792
+1518.4%
$795,8620.0%$1.19
40
2026-Q1
Increased
41,324
+25.3%
$69,8380.0%$1.69
18
2025-Q4
Decreased
32,989
-93.0%
$65,3180.0%$1.98
0
2025-Q3
Decreased
472,860
-22.9%
$1.4M0.0%$2.91
0
2025-Q2
Increased
613,143
+23.5%
$1.1M0.0%$1.81
31
2025-Q1
Increased
496,313
+78.0%
$744,4700.0%$1.50
38
2024-Q4
Increased
278,909
+82.4%
$658,2250.0%$2.36
38
2024-Q3
Increased
152,939
+79.4%
$4.5M0.0%$29.43
41
2024-Q2
Increased
85,245
+61.4%
$1.1M0.0%$12.35
36
2024-Q1
Decreased
52,831
-67.3%
$1.1M0.0%$20.29
0
2023-Q4
Increased
161,659
+203.8%
$3.6M0.0%$22.51
43
2023-Q3
Decreased
53,203
-18.8%
$885,2980.0%$16.64
0
2023-Q2
Increased
65,520
+3.2%
$1.6M0.0%$24.52
26
2023-Q1
Decreased
63,513
-60.1%
$1.5M0.0%$24.12
0
2022-Q4
Increased
159,247
+107.4%
$4.7M0.0%$29.54
43
2022-Q3
Increased
76,795
+104.5%
$3,2120.0%$41.82
22
2022-Q2
First report
37,557
-
$1,0560.0%$28.12
0

Other major holders of SAVA: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., STATE STREET CORP, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used